Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2015, Article ID 746873, 16 pages
http://dx.doi.org/10.1155/2015/746873
Research Article

Bone Marrow-Derived Multipotent Stromal Cells Promote Myocardial Fibrosis and Reverse Remodeling of the Left Ventricle

1Research Center for Obstetrics, Gynecology and Perinatology of Ministry of Healthcare of the Russian Federation, 4 Oparina Street, Moscow 117997, Russia
2Scientific Research Institute of Human Morphology, Russian Academy of Medical Sciences, 3 Tsurupa Street, Moscow 117418, Russia
3Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation, 1 Ostrovitianov Street, Moscow 117997, Russia
4Biological Testing Laboratory, Branch of Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, 6 Nauki Avenue, Pushchino 142290, Russia
5Research Centre of Medical Genetics of the Russian Academy of Medical Sciences, 1 Moskvorechie Street, Moscow 115478, Russia

Received 5 November 2014; Revised 28 December 2014; Accepted 28 December 2014

Academic Editor: Gary E. Lyons

Copyright © 2015 Timur Fatkhudinov et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Ikebe and K. Suzuki, “Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocols,” BioMed Research International, vol. 2014, Article ID 951512, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. N. C. Panda, S. T. Zuckerman, O. O. Mesubi et al., “Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel,” Journal of Interventional Cardiac Electrophysiology, vol. 41, no. 2, pp. 117–127, 2014. View at Publisher · View at Google Scholar
  3. E. Samper, A. Diez-Juan, J. A. Montero, and P. Sepúlveda, “Cardiac cell therapy: boosting mesenchymal stem cells effects,” Stem Cell Reviews and Reports, vol. 9, no. 3, pp. 266–280, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Tang, X. Gan, and R. Cheheltani, “Targeted delivery of vascular endothelial growth factor improves stem cell therapy in a rat myocardial infarction model,” Nanomedicine, vol. 10, no. 8, pp. 1711–1718, 2014. View at Publisher · View at Google Scholar
  5. Y. Sun, M. F. Kiani, A. E. Postlethwaite, and K. T. Weber, “Infarct scar as living tissue,” Basic Research in Cardiology, vol. 97, no. 5, pp. 343–347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. J. M. Duran, C. A. Makarewich, T. E. Sharp et al., “Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms,” Circulation Research, vol. 113, no. 5, pp. 539–552, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. T. J. Cashman, V. Gouon-Evans, and K. D. Costa, “Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms,” Stem Cell Reviews and Reports, vol. 9, no. 3, pp. 254–265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Y. Sheikh, S. A. Lin, F. Cao et al., “Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium,” Stem Cells, vol. 25, no. 10, pp. 2677–2684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-S. Huang, I.-H. Li, S.-H. Chueh et al., “Mesenchymal stem cells from rat olfactory bulbs can differentiate into cells with cardiomyocyte characteristics,” Journal of Tissue Engineering and Regenerative Medicine, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Ramesh, D. K. Bishi, S. Rallapalli, S. Arumugam, K. M. Cherian, and S. Guhathakurta, “Ischemic cardiac tissue conditioned media induced differentiation of human mesenchymal stem cells into early stage cardiomyocytes,” Cytotechnology, vol. 64, no. 5, pp. 563–575, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Gnecchi, H. He, L. G. Melo et al., “Early beneficial effects of bone marrow-derived mesenchymal stem cells overexpressing akt on cardiac metabolism after myocardial infarction,” Stem Cells, vol. 27, no. 4, pp. 971–979, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. A. S. Cheng and T. M. Yau, “Paracrine effects of cell transplantation: strategies to augment the efficacy of cell therapies,” Seminars in Thoracic and Cardiovascular Surgery, vol. 20, no. 2, pp. 94–101, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Fukuda and J. Fujita, “Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice,” Kidney International, vol. 68, no. 5, pp. 1940–1943, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Ikegami, S. Miyoshi, N. Nishiyama et al., “Serum-independent cardiomyogenic transdifferentiation in human endometrium-derived mesenchymal cells,” Artificial Organs, vol. 34, no. 4, pp. 280–288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Shinmura, I. Togashi, S. Miyoshi et al., “Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function,” Stem Cells, vol. 29, no. 2, pp. 357–366, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. A. Rose, H. Jiang, X. Wang et al., “Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro,” Stem Cells, vol. 26, no. 11, pp. 2884–2892, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Terada, T. Hamazaki, M. Oka et al., “Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion,” Nature, vol. 416, no. 6880, pp. 542–545, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. S. Burchfield and S. Dimmeler, “Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis,” Fibrogenesis and Tissue Repair, vol. 1, no. 1, article 4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Dai, S. L. Hale, and R. A. Kloner, “Role of a paracrine action of mesenchymal stem cells in the improvement of left ventricular function after coronary artery occlusion in rats,” Regenerative Medicine, vol. 2, no. 1, pp. 63–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Mias, O. Lairez, E. Trouche et al., “Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction,” Stem Cells, vol. 27, no. 11, pp. 2734–2743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Goussetis, A. Manginas, M. Koutelou et al., “Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution,” Stem Cells, vol. 24, no. 10, pp. 2279–2283, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. D. J. Prockop, “Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms,” Molecular Therapy, vol. 17, no. 6, pp. 939–946, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. A. W. Piastowska-Ciesielska, J. Drobnik, J. Zarzyńska, K. Domińska, J. A. Russell, and T. Ochedalski, “Influence of myocardial infarction on changes in the expression of angiotensin type 1 receptor in the rat prostate,” Folia Histochemica et Cytobiologica, vol. 49, no. 3, pp. 497–503, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. Z.-Q. Shao, K. Takaji, Y. Katayama et al., “Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model,” Circulation Journal, vol. 70, no. 4, pp. 471–477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Oliver-Dussault, A. Ascah, M. Marcil et al., “Early predictors of cardiac decompensation in experimental volume overload,” Molecular and Cellular Biochemistry, vol. 338, no. 1-2, pp. 271–282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Lancaster, E. Juneman, T. Hagerty et al., “Viable fibroblast matrix patch induces angiogenesis and increases myocardial blood flow in heart failure after myocardial infarction,” Tissue Engineering A, vol. 16, no. 10, pp. 3065–3073, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Dayan, Y. Hiss, A. Hirshberg, J. J. Bubis, and M. Wolman, “Are the polarization colors of Picrosirius red-stained collagen determined only by the diameter of the fibers?” Histochemistry, vol. 93, no. 1, pp. 27–29, 1989. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Dixon and F. G. Spinale, “Pathophysiology of myocardial injury and remodeling: implications for molecular imaging,” Journal of Nuclear Medicine, vol. 51, supplement 1, pp. 102S–106S, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Dominici, K. Le Blanc, I. Mueller et al., “Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for cellular therapy position statement,” Cytotherapy, vol. 8, no. 4, pp. 315–317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Garjani, S. Andalib, S. Biabani, H. Soraya, Y. Doustar, and N. Maleki-Dizaji, “Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat,” European Journal of Pharmacology, vol. 666, no. 1–3, pp. 135–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. N. A. Turner and K. E. Porter, “Function and fate of myofibroblasts after myocardial infarction,” Fibrogenesis and Tissue Repair, vol. 6, no. 1, article 5, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. K. T. Weber, Y. Sun, S. K. Bhattacharya, R. A. Ahokas, and I. C. Gerling, “Myofibroblast-mediated mechanisms of pathological remodelling of the heart,” Nature Reviews Cardiology, vol. 10, no. 1, pp. 15–26, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. H. K. Grøgaard, O. E. Sigurjonsson, M. Brekke et al., “Cardiac accumulation of bone marrow mononuclear progenitor cells after intracoronary or intravenous injection in pigs subjected to acute myocardial infarction with subsequent reperfusion,” Cardiovascular Revascularization Medicine, vol. 8, no. 1, pp. 21–27, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Jacob, L. Chang, and E. Puré, “Fibroblast activation protein in remodeling tissues,” Current Molecular Medicine, vol. 12, no. 10, pp. 1220–1243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. P. Daskalopoulos, B. J. A. Janssen, and W. M. Blankesteijn, “Myofibroblasts in the infarct area: concepts and challenges,” Microscopy and Microanalysis, vol. 18, no. 1, pp. 35–49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Ma, G. V. Halade, and M. L. Lindsey, “Extracellular matrix and fibroblast communication following myocardial infarction,” Journal of Cardiovascular Translational Research, vol. 5, no. 6, pp. 848–857, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Zannad, P. Rossignol, and W. Iraqi, “Extracellular matrix fibrotic markers in heart failure,” Heart Failure Reviews, vol. 15, no. 4, pp. 319–329, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. P. D. H. M. Verhaegen, P. P. M. van Zuijlen, N. M. Pennings et al., “Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis,” Wound Repair and Regeneration, vol. 17, no. 5, pp. 649–656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. B. Alberts, D. Bray, J. Lewis, M. Raff, K. Roberts, and J. D. Watson, Molecular Biology of the Cell, Garland Publishing, New York, NY, USA, 3rd edition, 1994.
  40. I. Stefanon, M. Valero-Muñoz, A. A. Fernandes et al., “Left and right ventricle late remodeling following myocardial infarction in rats,” PLoS ONE, vol. 8, no. 5, Article ID e64986, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. T. K. Fatkhudinov, J. P. Baikova, G. B. Bolshakova et al., “Effect of transplantation of bone marrow monomuclears on angiogenesis in rats,” Bulletin of Experimental Biology and Medicine, vol. 152, no. 1, pp. 120–123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Ishikane, H. Hosoda, K. Yamahara et al., “Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats,” Transplantation, vol. 96, no. 8, pp. 697–706, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Wu and R. C. H. Zhao, “The role of chemokines in mesenchymal stem cell homing to myocardium,” Stem Cell Reviews and Reports, vol. 8, no. 1, pp. 243–250, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Tano, T. Narita, M. Kaneko et al., “Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study,” Molecular Therapy, vol. 22, no. 10, pp. 1864–1871, 2014. View at Publisher · View at Google Scholar
  45. T. Freyman, G. Polin, H. Osman et al., “A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction,” European Heart Journal, vol. 27, no. 9, pp. 1114–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Numasawa, T. Kimura, S. Miyoshi et al., “Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis,” Stem Cells, vol. 29, no. 9, pp. 1405–1414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Bai, Y. Huang, X. Jia, Y. Fan, and W. Wang, “Endothelium oriented differentiation of bone marrow mesenchymal stem cells under chemical and mechanical stimulations,” Journal of Biomechanics, vol. 43, no. 6, pp. 1176–1181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. V. D. Roobrouck, S. A. Jacobs, F. Ulloa-Montoya et al., “Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions,” Stem Cells, vol. 29, no. 5, pp. 871–882, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Siegel, P. Krause, S. Wöhrle et al., “Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential,” Stem Cells and Development, vol. 21, no. 13, pp. 2457–2470, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Orlic, J. A. N. Kajstura, S. Chimenti, D. M. Bodine, A. Leri, and P. Anversa, “Transplanted adult bone marrow cells repair myocardial infarcts in mice,” Annals of the New York Academy of Sciences, vol. 938, pp. 221–230, 2001. View at Google Scholar · View at Scopus
  51. E. C. Perin, G. V. Silva, J. A. R. Assad et al., “Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 3, pp. 486–495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. N. Landa, L. Miller, M. S. Feinberg et al., “Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat,” Circulation, vol. 117, no. 11, pp. 1388–1396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Sun and K. T. Weber, “Infarct scar: a dynamic tissue,” Cardiovascular Research, vol. 46, no. 2, pp. 250–256, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Wang, R. Ansari, Y. Sun, A. E. Postlethwaite, K. T. Weber, and M. F. Kiani, “The scar neovasculature after myocardial infarction in rats,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 289, no. 1, pp. H108–H113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. T. K. Fatkhudinov, G. B. Bol'Shakova, S. V. Komissarova, I. V. Arutyunyan, A. A. Rzhaninova, and D. V. Goldstein, “Angiogenesis after transplantation of auto- and allogenic cells,” Bulletin of Experimental Biology and Medicine, vol. 149, no. 4, pp. 457–461, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Tang, J. Wang, L. Guo et al., “Mesenchymal stem cells modified with stromal cell-derived factor 1α improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction,” Molecules and Cells, vol. 29, no. 1, pp. 9–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Tamama and S. S. Kerpedjieva, “Acceleration of wound healing by multiple growth factors and cytokines secreted from multipotential stromal cells/mesenchymal stem cells,” Advances in Wound Care, vol. 1, no. 4, pp. 177–182, 2012. View at Publisher · View at Google Scholar
  58. M. Madrigal, K. S. Rao, and N. H. Riordan, “A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods,” Journal of Translational Medicine, vol. 12, no. 1, article 260, 2014. View at Publisher · View at Google Scholar
  59. J. Yu, S. Yin, W. Zhang et al., “Hypoxia preconditioned bone marrow mesenchymal stem cells promote liver regeneration in a rat massive hepatectomy model,” Stem Cell Research and Therapy, vol. 4, article 83, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. T. Kawakami, I. Mimura, K. Shoji, T. Tanaka, and M. Nangaku, “Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes,” Kidney International Supplements, vol. 4, no. 1, pp. 107–112, 2014. View at Publisher · View at Google Scholar
  61. D. Zisa, A. Shabbir, G. Suzuki, and T. Lee, “Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair,” Biochemical and Biophysical Research Communications, vol. 390, no. 3, pp. 834–838, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. R. A. Boomsma and D. L. Geenen, “Mesenchymal stem cells secrete multiple cytokines that promote angiogenesis and have contrasting effects on chemotaxis and apoptosis,” PloS ONE, vol. 7, no. 4, Article ID e35685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. A. T. Askari, S. Unzek, Z. B. Popovic et al., “Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy,” Lancet, vol. 362, no. 9385, pp. 697–703, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. O. I. Eseonu and C. De Bari, “Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis,” Rheumatology, 2014. View at Publisher · View at Google Scholar
  65. F. Dong, J. Harvey, A. Finan, K. Weber, U. Agarwal, and M. S. Penn, “Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction,” Circulation, vol. 126, no. 3, pp. 314–324, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Ding, K. Hori, R. Zhang et al., “Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS),” Wound Repair and Regeneration, vol. 19, no. 5, pp. 568–578, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. L. H. Shen, Y. Li, J. Chen et al., “Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 1, pp. 6–13, 2007. View at Publisher · View at Google Scholar · View at Scopus